Breast Cancer Resources

home  »  cancer resources »  breast cancer

Breast Cancer Treatment Research and Sources of Information & Support

Kenneth S. Pope, Ph.D., ABPP

I gathered the resources on this page to help people with breast cancer and their loved ones to find information, support, and other resources. These resources are meant to complement and not replace any advice or information from a health care professional.

I created this site to be fully accessible for people with disabilities; please follow this link to change text size, color, or contrast; please follow this link for other accessibility functions for those with visual, mobility, and other disabilities.

There are 4 sections of resources:

1) 21 Books for learning about breast cancer, exploring treatment options, & coping effectively

2) 28 Recent articles (i.e., published in October, 2019-2020 on psychological aspects of breast cancer

3) 51 Recent (i.e., published in 2020) research articles on breast cancer treatments

4) Links to 21 web sites providing information and support

PLEASE NOTE: This web site includes 8 other pages of related sets of resources:



An Y, Fu G, Yuan G. 2019. Quality of life in patients with breast cancer: The influence of family caregiver's burden and the mediation of patient's anxiety and depression. Journal of Nervous and Mental Disease 207: 921-26

Blommaert J, Schroyen G, Vandenbulcke M, Radwan A, Smeets A, et al. 2019. Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients. Human Brain Mapping 40: 4994-5010

Bourdon M, Blanchin M, Campone M, Quéreux G, Dravet F, et al. 2019. A comparison of posttraumatic growth changes in breast cancer and melanoma. Health Psychology 38: 878-87

Brown SL, Hughes M, Campbell S, Cherry MG. 2019. Could worry and rumination mediate relationships between self-compassion and psychological distress in breast cancer survivors? Clinical Psychology & Psychotherapy: published online prior to print publication

Chan A, Lomma C, Chih H, Arto C, McDonald F, et al. 2019. Psychosocial consequences in offspring of women with breast cancer. Psycho-Oncology: published online prior to print publication

Chu Q, Wu IHC, Lu Q. 2020. Expressive writing intervention for posttraumatic stress disorder among chinese american breast cancer survivors: The moderating role of social constraints. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation: published online prior to print publication

Cohen M, Levkovich I, Pollack S, Fried G. 2019. Stability and change of postchemotherapy symptoms in relation to optimism and subjective stress: A prospective study of breast cancer survivors. Psycho-Oncology 28: 2017-24

Conley CC, Ketcher D, Reblin M, Kasting ML, Cragun D, et al. 2020. The big reveal: Family disclosure patterns of brca genetic test results among young black women with invasive breast cancer. Journal of Genetic Counseling: published online prior to print publication

Del Piccolo L, Mazzi MA, Mascanzoni A, Lonardi M, De Felice M, et al. 2019. Factors related to the expression of emotions by early-stage breast cancer patients. Patient Education and Counseling 102: 1767-73

Green HJ, Mihuta ME, Ownsworth T, Dhillon HM, Tefay M, et al. 2019. Adaptations to cognitive problems reported by breast cancer survivors seeking cognitive rehabilitation: A qualitative study. Psycho-Oncology 28: 2042-48

Grimley CE, Kato PM, Grunfeld EA. 2020. Health and health belief factors associated with screening and help-seeking behaviours for breast cancer: A systematic review and meta-analysis of the European evidence. British Journal of Health Psychology 25: 107-28

Han J, Liu J-E, Su Y-L, Qiu H. 2019. Effect of a group-based acceptance and commitment therapy (ACT) intervention on illness cognition in breast cancer patients. Journal of Contextual Behavioral Science 14: 73-81

Henneghan AM, Gibbons C, Harrison RA, Edwards ML, Rao V, et al. 2020. Predicting patient reported outcomes of cognitive function using connectome-based predictive modeling in breast cancer. Brain Topography 33: 135-42

Jiang X, Yang Y, Li H, Li S, Su D, et al. 2019. An intervention based on protective factors to improve resilience for breast cancer patients: Study protocol for a randomized controlled trial. Journal of Advanced Nursing 75: 3088-96

Meadows RJ, Nolan TS, Paxton RJ. 2019. Spiritual health locus of control and life satisfaction among african american breast cancer survivors. Journal of Psychosocial Oncology: published online prior to print publication

Meier F, Cairo Notari S, Bodenmann G, Revenson TA, Favez N. 2019. We are in this together — aren't we? Congruence of common dyadic coping and psychological distress of couples facing breast cancer. Psycho-Oncology: published online prior to print publication

Mikal JP, Beckstrand MJ, Grande SW, Parks E, Oyenuga M, et al. 2020. Online support seeking and breast cancer patients: Changes in support seeking behavior following diagnosis and transition off cancer therapy. Health Communication: published online prior to print publication

Napoli M, Lewis J, Hopper J, Widmeyer K. 2020. Factors that impact risk management decisions among women with pathogenic variants in moderate penetrance genes associated with hereditary breast cancer. Journal of Genetic Counseling: published online prior to print publication

Pergolizzi D, Root JC, Pan H, Silbersweig D, Stern E, et al. 2019. Episodic memory for visual scenes suggests compensatory brain activity in breast cancer patients: A prospective longitudinal fMRI study. Brain Imaging and Behavior 13: 1674-88

Pidduck W, Wan BA, Zhang L, Chow S, Yee C, et al. 2019. Seasonal fluctuations in psychological distress amongst women diagnosed with early breast cancer receiving radiotherapy. Psycho-Oncology 28: 2091-97

Romeo A, Di Tella M, Ghiggia A, Tesio V, Torta R, Castelli L. 2020. Posttraumatic growth in breast cancer survivors: Are depressive symptoms really negative predictors? Psychological Trauma: Theory, Research, Practice, and Policy 12: 244-50

Shim E-J, Jeong D, Moon H-G, Noh D-Y, Jung S-Y, et al. 2019. Profiles of depressive symptoms and the association with anxiety and quality of life in breast cancer survivors: A latent profile analysis. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation: published online prior to print publication

Sipilä R, Hintsa T, Lipsanen J, Tasmuth T, Estlander AM, Kalso E. 2019. The relationship between anger regulation, mood, pain, and pain-related disability in women treated for breast cancer. Psycho-Oncology 28: 2002-08

Todorov N, Sherman KA, Kilby CJ. 2019. Self-compassion and hope in the context of body image disturbance and distress in breast cancer survivors. Psycho-Oncology 28: 2025-32

Toscano A, Blanchin M, Bourdon M, Bonnaud Antignac A, Sébille V. 2020. Longitudinal associations between coping strategies, locus of control and health-related quality of life in patients with breast cancer or melanoma. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation: published online prior to print publication

Warmoth K, Yeung NCY, Xie J, Feng H, Loh A, et al. 2020. Benefits of a psychosocial intervention on positive affect and posttraumatic growth for Chinese American breast cancer survivors: A pilot study. Behavioral Medicine 46: 34-42

Wong CCY, Pan-Weisz BM, Pan-Weisz TM, Yeung NCY, Mak WWS, Lu Q. 2019. Self-stigma predicts lower quality of life in Chinese American breast cancer survivors: Exploring the mediating role of intrusive thoughts and posttraumatic growth. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation 28: 2753-60

Zhu Y, Glowacki EM, Yang Y. 2020. A social ties-based approach to breast cancer patients’ quality of life: Examining group ties and individual ties across offline and online settings. Health Communication: published online prior to print publication


  1. Ahn S, Woo JW, Lee K, Park SY. 2020. HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation. J Pathol Transl Med 54: 34-44

  2. Almahariq MF, Quinn TJ, Siddiqui Z, Jawad MS, Chen PY, et al. 2020. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer. Radiother Oncol 142: 186-94

  3. Alvarez-Lopez I, Bezares S, Dalmau Portulas E, Garcia-Martinez E, Garcia-Saenz JA, et al. 2020. Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer. Clin Transl Oncol

  4. Baek DW, Park JY, Lee SJ, Chae YS. 2020. Impressive effect of cisplatin monotherapy on a patient with heavily pretreated triple-negative breast cancer with poor performance. Yeungnam Univ J Med

  5. Banerjee SM, El-Sheikh S, Malhotra A, Mosse CA, Parker S, et al. 2020. Photodynamic Therapy in Primary Breast Cancer. J Clin Med 9

  6. Battisti NML, True V, Chaabouni N, Chopra N, Lee K, et al. 2020. Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience. Breast Cancer Res Treat 179: 101-11

  7. Benson JR, Jatoi I. 2020. Extended endocrine therapy in early breast cancer: how long and who for? Future Oncol 16: 4327-36

  8. Bonet M, Garcia V, Farre N, Algara M, Farrus B, et al. 2020. Radiation therapy for bone-only metastases in breast cancer patients: A GOCO survey of current clinical practice. Rep Pract Oncol Radiother 25: 113-16

  9. Camejo N, Castillo C, Alonso R, Correa F, Rivero E, et al. 2020. Effectiveness of Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in a Real-Life Setting: One Decade of Experience Under National Treatment Coverage Regulations. JCO Glob Oncol 6: 217-23

  10. Chang-Qing Y, Jie L, Shi-Qi Z, Kun Z, Zi-Qian G, et al. 2020. Recent treatment progress of triple negative breast cancer. Prog Biophys Mol Biol 151: 40-53

  11. Chen XS, Wang KS, Guo W, Li LY, Yu P, et al. 2020. UCH-L1-mediated Down-regulation of Estrogen Receptor alpha Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics 10: 1833-48

  12. Cheng X, Zeng X, Zheng Y, Fang Q, Wang X, et al. 2020. pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy. J Colloid Interface Sci 565: 254-69

  13. Chou YH, Huang JY, Kornelius E, Chiou JY, Huang CN. 2020. Major Adverse Cardiovascular Events after Treatment in Early-stage Breast Cancer Patients Receiving Hormone Therapy. Sci Rep 10: 1408

  14. Clatot F, Fontanilles M, Lefebvre L, Lequesne J, Veyret C, et al. 2020. Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer. Eur J Cancer 126: 116-24

  15. Coleman R, Finkelstein DM, Barrios C, Martin M, Iwata H, et al. 2020. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 21: 60-72

  16. Czajka ML, Pfeifer C. 2020. Breast Cancer Surgery In StatPearls. Treasure Island (FL)

  17. De Groef A, Devoogdt N, Van Kampen M, De Hertogh L, Vergote M, et al. 2020. The effectiveness of Botulinum Toxin A for treatment of upper limb impairments and dysfunctions in breast cancer survivors: A randomised controlled trial. Eur J Cancer Care (Engl) 29: e13175

  18. Deng L, Fan J, Ding Y, Yang X, Huang B, Hu Z. 2020. Target Therapy With Vaccinia Virus Harboring IL-24 For Human Breast Cancer. J Cancer 11: 1017-26

  19. Dixon JM, Cartlidge CWJ. 2020. Twenty-five years of change in the management of the axilla in breast cancer. Breast J 26: 22-26

  20. El Khalki L, Maire V, Dubois T, Zyad A. 2020. Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses. Molecules 25

  21. Feinberg B, Kish J, Dokubo I, Wojtynek J, Gajra A, Lord K. 2020. Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real-World Evidence Analysis. Oncologist

  22. Fohlin H, Bekkhus T, Sandstrom J, Fornander T, Nordenskjold B, et al. 2020. RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer. Oncol Lett 19: 52-60

  23. Fujita N, Enomoto Y, Inakami K, Yanagisawa T, Iguchi C, et al. 2020. Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab. Oncology 98: 35-41

  24. Gannon MR, Dodwell D, Jauhari Y, Horgan K, Clements K, et al. 2020. Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England. J Geriatr Oncol

  25. Gao JJ, Cheng J, Bloomquist E, Sanchez J, Wedam SB, et al. 2020. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis. Lancet Oncol 21: 250-60

  26. Gold HT, Shao H, Oratz R, Yu O, Hammer M, et al. 2020. Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer. Am J Clin Oncol 43: 101-06

  27. Gong Z, Chen M, Ren Q, Yue X, Dai Z. 2020. Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer. Signal Transduct Target Ther 5: 12

  28. Greenwalt I, Zaza N, Das S, Li BD. 2020. Precision Medicine and Targeted Therapies in Breast Cancer. Surg Oncol Clin N Am 29: 51-62

  29. Hasenoehrl T, Keilani M, Palma S, Crevenna R. 2020. Resistance exercise and breast cancer related lymphedema - a systematic review update. Disabil Rehabil 42: 26-35

  30. He T, Yang W, Zhang X, Li P, Yang D, et al. 2020. Comparative effectiveness of tamoxifen, toremifene, letrozole, anastrozole, and exemestane on lipid profiles in breast cancer patients: A network meta-analysis. Medicine (Baltimore) 99: e18550

  31. Heil J, Kuerer HM, Pfob A, Rauch G, Sinn HP, et al. 2020. Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges. Ann Oncol 31: 61-71

  32. Henson KE, McGale P, Darby SC, Parkin DM, Wang Y, Taylor CW. 2020. Cardiac Mortality after Radiotherapy, Chemotherapy and Endocrine Therapy for Breast Cancer: Cohort Study of 2 Million Women from 57 Cancer Registries in 22 Countries. Int J Cancer

  33. Herrscher H, Velten M, Leblanc J, Kalish-Weindling M, Fischbach C, et al. 2020. Fulvestrant and palbociclib combination in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer patients. Breast Cancer Res Treat 179: 371-76

  34. Hui R, Pearson A, Cortes J, Campbell C, Poirot C, et al. 2020. Lucitanib for the Treatment of HR(+)/HER2(-) Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study. Clin Cancer Res 26: 354-63

  35. Huynh MM, Jayanthan A, Pambid MR, Los G, Dunn SE. 2020. RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer. Expert Opin Ther Targets 24: 1-5

  36. Iwata H, Saji S, Ikeda M, Inokuchi M, Uematsu T, et al. 2020. The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient. Breast Cancer 27: 1-3

  37. Jordan RM, Vandeverveken RL, Oxenberg J. 2020. Breast Cancer Conservation Therapy In StatPearls. Treasure Island (FL)

  38. Kayali M, Abi Jaoude J, Tfayli A, El Saghir N, Poortmans P, Zeidan YH. 2020. Post-mastectomy radiation therapy in breast cancer patients with 1-3 positive lymph nodes: No one size fits all. Crit Rev Oncol Hematol 147: 102880

  39. Khoobchandani M, Katti KK, Karikachery AR, Thipe VC, Srisrimal D, et al. 2020. New Approaches in Breast Cancer Therapy Through Green Nanotechnology and Nano-Ayurvedic Medicine - Pre-Clinical and Pilot Human Clinical Investigations. Int J Nanomedicine 15: 181-97

  40. Lerebours F, Pulido M, Fourme E, Debled M, Becette V, et al. 2020. Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials. Br J Cancer

  41. Leung CN, Canter BS, Rajon D, Back TA, Fritton JC, et al. 2020. Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with (223)Ra: The Role of Bystander Effects and Their Potential for Therapy. J Nucl Med 61: 89-95

  42. Li J, Fu F, Yu L, Huang M, Lin Y, et al. 2020. Cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer: a meta-analysis of randomized clinical trials. Breast Cancer Res Treat

  43. Li J, Li M, Tian L, Qiu Y, Yu Q, et al. 2020. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy. Int J Pharm 578: 119122

  44. Li Y, Chen X, Zhou Z, Li Q, Westover KD, et al. 2020. Dynamic surveillance of tamoxifen-resistance in ER-positive breast cancer by CAIX-targeted ultrasound imaging. Cancer Med

  45. Li Y, Li X, Lu Y, Chaurasiya B, Mi G, et al. 2020. Co-delivery of Poria cocos extract and doxorubicin as an 'all-in-one' nanocarrier to combat breast cancer multidrug resistance during chemotherapy. Nanomedicine 23: 102095

  46. Miyashita M, Hattori M, Takano T, Toyama T, Iwata H. 2020. Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials. Breast Cancer

  47. Murthy RK, Loi S, Okines A, Paplomata E, Hamilton E, et al. 2020. Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer. N Engl J Med 382: 597-609

  48. Pasquier D, Darlix A, Louvel G, Fraisse J, Jacot W, et al. 2020. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort. Eur J Cancer 125: 22-30

  49. Remick J, Amin NP. 2020. Postmastectomy Breast Cancer Radiation Therapy In StatPearls. Treasure Island (FL)

  50. Roberts KE, Rickett K, Feng S, Vagenas D, Woodward NE. 2020. Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database Syst Rev 1: CD012988

  51. Rossi L, Longhitano C, Kola F, Del Grande M. 2020. State of art and advances on the treatment of bone metastases from breast cancer: a concise review. Chin Clin Oncol




[Back to Top]